medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2016-9-28-32medsovet-1379Research ArticleНЕВРОЛОГИЯNEUROLOGYЛечение пожилых пациентов с дорсопатиейTREATMENT OF ELDERLY PATIENTS WITH DORSOPATHYКАМЧАТНОВП. Р.KAMCHATNOVP. R.

д.м.н., профессор

MD, Prof.

ЕВЗЕЛЬМАНМ. А.EVZELMANM. A.

д.м.н., профессор

MD., Prof.

ЧУГУНОВА. В.CHUGUNOVA. V.

к.м.н

PhD

Российский национальный медицинский исследовательский университет им. Н.И. Пирогова, МоскваРоссияPirogov Russian National Medical Research Institute, MoscowRussian FederationОрловский государственный университет — Медицинский институтРоссияOrlov State University – Medical InstituteRussian Federation201630122016092832Copyright © КАМЧАТНОВ П.Р., ЕВЗЕЛЬМАН М.А., ЧУГУНОВ А.В., 20162016КАМЧАТНОВ П.Р., ЕВЗЕЛЬМАН М.А., ЧУГУНОВ А.В.KAMCHATNOV P.R., EVZELMAN M.A., CHUGUNOV A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1379

Дорсопатия – исключительно распространенный в популяции скелетно-мышечный болевой синдром. Для лечения пациентов с дорсопатиями наиболее широко используются нестероидные противовоспалительные препараты. Как правило, они оказывают выраженные противоболевой и противовоспалительный эффекты, однако их использование ассоциировано с риском развития побочных эффектов, особенно высоким у пациентов с полиморбидностью, нуждающихся в одновременном приеме нескольких лекарственных препаратов. Рассматривается возможность применения трансдермальной формы диклофенака (Вольтарен Эмульгель) у пациентов с дорсопатиями. Приводятся результаты исследований, посвященных изучению биодоступности препарата, его эффективности и переносимости.

Dorsopathy is skeletal and muscular pain syndrome very wide-spread in the population. Non-steroid anti-inflammatory drugs are used for therapy of patients with dorsopathies. As a rule, they produce pronounced analgetic and anti-inflammatory effects, but their use is associated with a risk of side effects development, especially high in patients with polymorbidity requiring simultaneous administration of several drugs. A possibility to use a transdermal form of diclofenac (Voltaren Emulgel) in dorsopathy patients. Study results devoted to study of the drug biological availability, its effectiveness and tolerability are provided.

дорсопатиятерапиядиклофенактрансдермальные лекарственные формыdorsopathytherapyDiclofenactransdermal dosage formsReferencesParsons S, Breen A, Foster N. Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations. Fam Pract, 2007, 24: 308-16. doi: 10.1093/fampra/ cmm027.Parsons S, Breen A, Foster N. Prevalence and comparative troublesomeness by age of musculoskeletal pain in different body locations. Fam Pract, 2007, 24: 308-16. doi: 10.1093/fampra/ cmm027.Hall H, McIntosh G. Low back pain (acute). Clin Evid, 2008, 43: 1102-1108.Hall H, McIntosh G. Low back pain (acute). Clin Evid, 2008, 43: 1102-1108.Puntumetakul R, Yodchaisarn W, Emasithi A, Keawduangdee P, Chatchawan U, Yamauchi J. Prevalence and individual risk factors associated with clinical lumbar instability in ricefarmers with low back pain. Patient Prefer Adherence, 2015, 9: 1-7. doi: 10.2147/PPA.S73412.Puntumetakul R, Yodchaisarn W, Emasithi A, Keawduangdee P, Chatchawan U, Yamauchi J. Prevalence and individual risk factors associated with clinical lumbar instability in ricefarmers with low back pain. Patient Prefer Adherence, 2015, 9: 1-7. doi: 10.2147/PPA.S73412.Есин Р.Г., Лотфуллина Н.З., Есин О.Р. Цервикалгия, дорзалгия, люмбалгия. Дифференциальная диагностика, дифференцированная терапия. Казань. ИИЦ УД Президента РТ. Казань, 2015./ Esin R.G., Lotfullina N.Z., Esin O.R. Cervilcalgia, dorsalgia, lumbalfia. Differential diagnostics, differentiated therapy. Kazan. Information and Publishing Center of RT President Affairs Management Office. Kazan, 2015.Есин Р.Г., Лотфуллина Н.З., Есин О.Р. Цервикалгия, дорзалгия, люмбалгия. Дифференциальная диагностика, дифференцированная терапия. Казань. ИИЦ УД Президента РТ. Казань, 2015./ Esin R.G., Lotfullina N.Z., Esin O.R. Cervilcalgia, dorsalgia, lumbalfia. Differential diagnostics, differentiated therapy. Kazan. Information and Publishing Center of RT President Affairs Management Office. Kazan, 2015.da Costa B, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of nonsteroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. The Lancet. Published online:17 March 2016/ OI: http://dx.doi. org/10.1016/S0140-6736(16)30002-2.da Costa B, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of nonsteroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. The Lancet. Published online:17 March 2016/ OI: http://dx.doi. org/10.1016/S0140-6736(16)30002-2.Helin-Salmivaara A, Saarelainenb S, Grönroosci J, Vesalainend R, Klaukkae T, Huupponenf R. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scandinavian Journal of Gastroenterology, 2007, 42: 923-932. DOI: 10.1080/00365520701192326.Helin-Salmivaara A, Saarelainenb S, Grönroosci J, Vesalainend R, Klaukkae T, Huupponenf R. Risk of upper gastrointestinal events with the use of various NSAIDs: A case-control study in a general population. Scandinavian Journal of Gastroenterology, 2007, 42: 923-932. DOI: 10.1080/00365520701192326.Ray W, Varas-Lorenzo C, Chung C, Castellsague J, Murray K. MScCardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospita lization for Serious Coronary Heart Disease. Circ Cardiovasc Qual Outcomes, 2009, 2: 155-163. DOI: 10.1161/ CIRCOUTCOMES.108.805689.Ray W, Varas-Lorenzo C, Chung C, Castellsague J, Murray K. MScCardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospita lization for Serious Coronary Heart Disease. Circ Cardiovasc Qual Outcomes, 2009, 2: 155-163. DOI: 10.1161/ CIRCOUTCOMES.108.805689.OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 2014, 22: 363-388.OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage, 2014, 22: 363-388.McGettigan P, Henry D. Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies. PLoS Med, 2011, 8(9): e1001098. doi:10.1371/journal.pmed.1001098.McGettigan P, Henry D. Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies. PLoS Med, 2011, 8(9): e1001098. doi:10.1371/journal.pmed.1001098.Lanas A, Garcia-Tell G, Armada B, Oteo-Alvaro A. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med, 2011, 9: 38.Lanas A, Garcia-Tell G, Armada B, Oteo-Alvaro A. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med, 2011, 9: 38.Brooks J, Warburton R, Beales I. Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis, 2013, 4(5): 206-222. DOI: 10.1177/ 2040622313492188Brooks J, Warburton R, Beales I. Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis, 2013, 4(5): 206-222. DOI: 10.1177/ 2040622313492188Hsu C, Wang H, Hsu Y, Chuang S. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study. Hypertension, 2015, 66(3): 524-33. doi: 10.1161/HYPERTENSIONAHA.114.05105. Epub 2015 Jul 13.Hsu C, Wang H, Hsu Y, Chuang S. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study. Hypertension, 2015, 66(3): 524-33. doi: 10.1161/HYPERTENSIONAHA.114.05105. Epub 2015 Jul 13.Imamura T. Significant Efficacy of Tramadol/ Acetaminophen in Elderly Patients with Chronic Low Back Pain Uncontrolled by NSAIDs: An Observational Study. Open Orthop J, 2015, 9: 120-5. doi: 10.2174/1874325001509010120. eCollection 2015.Imamura T. Significant Efficacy of Tramadol/ Acetaminophen in Elderly Patients with Chronic Low Back Pain Uncontrolled by NSAIDs: An Observational Study. Open Orthop J, 2015, 9: 120-5. doi: 10.2174/1874325001509010120. eCollection 2015.Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with overthe- counter NSAIDs. Ther Clin Risk Manag, 2015, 11: 1061-75. doi: 10.2147/TCRM.S79135.Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with overthe- counter NSAIDs. Ther Clin Risk Manag, 2015, 11: 1061-75. doi: 10.2147/TCRM.S79135.Lip G. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2015, 13(9): 963-5. doi: 10.1586/14779072.2015. 1071665. Epub 2015 Jul 21.Lip G. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2015, 13(9): 963-5. doi: 10.1586/14779072.2015. 1071665. Epub 2015 Jul 21.Mason L, Moore A, Edwards J, Derry S. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord, 2004, 5: 28. doi: 10.1186/1471-2474-5-28.Mason L, Moore A, Edwards J, Derry S. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord, 2004, 5: 28. doi: 10.1186/1471-2474-5-28.Baboota S, Shakeel F, Kohli K. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine. Methods Find Exp Clin Pharmacol, 2006 Mar, 28(2): 109-14.Baboota S, Shakeel F, Kohli K. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine. Methods Find Exp Clin Pharmacol, 2006 Mar, 28(2): 109-14.Parsaee S, Sarbolouki MN, Parnianpour M. In–vitro release of diclofenac iethylammonium from lipid–based formulations. Int J Pharm, 2002, 241(1): 185-90. doi:10.1016/S0378- 5173(02)00238-7Parsaee S, Sarbolouki MN, Parnianpour M. In–vitro release of diclofenac iethylammonium from lipid–based formulations. Int J Pharm, 2002, 241(1): 185-90. doi:10.1016/S0378- 5173(02)00238-7Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M. The percutaneous absorption of diclofenac. Arzneimittelforschung, 1986, 36(7): 1092-1096.Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M. The percutaneous absorption of diclofenac. Arzneimittelforschung, 1986, 36(7): 1092-1096.Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol, 1991, 31(5): 537-541.Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frolich JC. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol, 1991, 31(5): 537-541.Brune K. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr Med Res Opin, 2007, 23: 2985-2995. doi: 10.1185/030079907X242584.Brune K. Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr Med Res Opin, 2007, 23: 2985-2995. doi: 10.1185/030079907X242584.Hasler-Nguyen N, Fotopoulos G. Effect of rubbing on the in vitro skin permeation of diclofenacdiethylamine1,16% gel. BMC Res Notes, 2012 Jun 21, 5: 321. doi: 10.1186/1756-0500-5-321.Hasler-Nguyen N, Fotopoulos G. Effect of rubbing on the in vitro skin permeation of diclofenacdiethylamine1,16% gel. BMC Res Notes, 2012 Jun 21, 5: 321. doi: 10.1186/1756-0500-5-321.El-Hadidi T, el-Garf A. Double-blind study comparing the use of Voltaren Emulgel versus regular gel during ultrasonic sessions in the treatment of localized traumatic and rheumatic painful conditions. J Int Med Res, 1991, 19(3): 219-227.El-Hadidi T, el-Garf A. Double-blind study comparing the use of Voltaren Emulgel versus regular gel during ultrasonic sessions in the treatment of localized traumatic and rheumatic painful conditions. J Int Med Res, 1991, 19(3): 219-227.Rosim GC, Barbieri CH, Lancas FM, Mazzer N. Diclofenac phonophoresis in human volunteers. Ultrasound Med Biol, 2005, 31(3): 337-343. DOI: ttp://dx.doi.org/10.1016/j.ultrasmedbio. 2004.11.012.Rosim GC, Barbieri CH, Lancas FM, Mazzer N. Diclofenac phonophoresis in human volunteers. Ultrasound Med Biol, 2005, 31(3): 337-343. DOI: ttp://dx.doi.org/10.1016/j.ultrasmedbio. 2004.11.012.Niethard FU, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH, Elkik F. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol., 2005 Dec, 32(12): 2384-92.Niethard FU, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH, Elkik F. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol., 2005 Dec, 32(12): 2384-92.Zacher J, Altman R, Bellamy N, Brühlmann P, Da Silva J, Huskisson E, Taylor RS. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin, 2008 Apr, 24(4): 925-50. doi: 0.1185/030079908X273066.Zacher J, Altman R, Bellamy N, Brühlmann P, Da Silva J, Huskisson E, Taylor RS. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin, 2008 Apr, 24(4): 925-50. doi: 0.1185/030079908X273066.Predel H, Bruno G, Pabst H, Schaefer A, Hug A, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo- controlled study. BMC Musculoskelet Disord, 2013, 14: 250. doi: 10.1186/1471-2474-14-250.Predel H, Bruno G, Pabst H, Schaefer A, Hug A, Burnett I. Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo- controlled study. BMC Musculoskelet Disord, 2013, 14: 250. doi: 10.1186/1471-2474-14-250.Шостак Н.А. Боль в спине – дифференциальная диагностика и лечение. Врач, 2009, 12: 34-38./ Shostak N.A. Pain in back – differential diagnostics and therapy. Vrach, 2009, 12: 34-38.Шостак Н.А. Боль в спине – дифференциальная диагностика и лечение. Врач, 2009, 12: 34-38./ Shostak N.A. Pain in back – differential diagnostics and therapy. Vrach, 2009, 12: 34-38.Инструкция по медицинскому применению препарата Вольтарен Эмульгель 2%./Voltaren Emulgel 2% Patient Information Leaflet.Инструкция по медицинскому применению препарата Вольтарен Эмульгель 2%./Voltaren Emulgel 2% Patient Information Leaflet.

The authors declare that there are no conflicts of interest present.